Anything coming up?, page-8

With legacy issues behind them and the large impairments (hopefully) taken in the last FY16, should hopefully see improved margins albeit on a reduced revenue base.

From managements recent shareholder addresses and reports, I'm generally under the impression that debt covenants should be comfortably met without significant dilution and/or further leverage. Circa $20 - $25M debt with HY17 PBT forecast to come in at around $5M, I believe that they should be able to fund repayments from internally generated cash. Add to that the significant Tax-Loss Carry-Forward they will likely be eligible to infuse into FY17 earnings and that should provide significant tax relief going forward as well.